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CAPSULE 
 
Background: Cytochrome c oxidase (COX), 
the final enzyme of the mitochondrial electron 
transport chain, requires several assembly 
factors for its proper function. 
Results: ccdc56-Knock-out flies showed 
developmental delay, lethality and a dramatic 
decrease in the levels/ activity of COX. 
Conclusion: CCDC56 protein is necessary for 
COX function and for viability in flies.  
Significance: Drosophila-CCDC56 is a novel 
putative COX assembly factor conserved in 
humans. 
 
SUMMARY 
In Drosophila melanogaster, the 
mitochondrial transcription factor B1 (d-
mtTFB1) transcript contains in its 5’-
untranslated region a conserved upstream 
Open Reading Frame (uORF) denoted as 
CG42630 in FlyBase. We demonstrate that 
CG42630 encodes a novel protein: the 
Coiled-Coil Domain Containing protein 56, 
CCDC56, conserved in metazoans. We show 
that Drosophila CCDC56 protein localizes 
to mitochondria and contains 87 amino 
acids in flies and 106 in humans, with the 
two proteins sharing 42% amino acid 
identity. We show by Rapid Amplification 
of cDNA Ends (RACE) and Northern-
blotting that Drosophila CCDC56 protein 
and mtTFB1 are encoded on a bona fide 
bicistronic transcript. We report the 
generation and characterization of two 
ccdc56 knockout lines in Drosophila 
carrying the ccdc56D6 and ccdc56D11 alleles. 
Lack of the CCDC56 protein in flies induces 
a developmental delay and 100% lethality 
by arrest of larval development at the third 
instar. ccdc56 knockout larvae show a 
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significant decrease in the level of fully-
assembled cytochrome c oxidase (COX) and 
in its activity, suggesting a defect in complex 
assembly; the activity of the other Oxidative 
Phosphorylation (OXPHOS) complexes 
remained either unaffected or increased in 
the ccdc56 knockout larvae. The lethal 
phenotype and the decrease in COX were 
rescued partially by reintroduction of a 
wild-type UAS-CCDC56 transgene. These 
results indicate an important role for 
CCDC56 in the OXPHOS system and in 
particular in COX function, required for 
proper development in Drosophila 
melanogaster. We propose CCDC56 as a 
candidate factor required for COX 
biogenesis/ assembly.  
 
INTRODUCTION 
 
Cytochrome c oxidase (COX) or 
Complex IV (EC 1.3.9.1) is the terminal 
enzyme of the electron transport chain, and 
catalyzes electron transfer from reduced 
cytochrome c to molecular oxygen. Most 
cellular ATP is produced in mitochondria by 
the oxidative phosphorylation (OXPHOS) 
system comprising the electron transport chain 
complexes (plus two electron carriers, 
coenzyme Q and cytochrome c) and the 
multimeric ATP-synthase (complex V) (1). 
The energy released from the oxidation of 
carbohydrates and lipids is converted to 
reducing power (NADH + H+ and FADH2) in 
the mitochondrial matrix. The electron 
transport chain couples electron transfer from 
NADH and FADH2 to molecular oxygen, with 
the proton translocation from the matrix to the 
mitochondrial intermembrane space by 
complexes I, III and IV. This proton 
translocation generates an electrochemical 
gradient that is used by complex V to generate 
ATP from ADP and inorganic phosphate. 
Eukaryotic COX is a heteromeric 
enzyme of dual genetic origin (2,3). The 
catalytic core of the enzyme is composed of 
three subunits encoded in the mitochondrial 
DNA (mtDNA): mt-CO1, mt-CO2 and mt-
CO3. The structural subunits that surround the 
catalytic core are encoded by the nuclear 
genome (nDNA)(4). The nDNA-encoded 
subunits must be imported into the 
mitochondria, processed and assembled 
together with the mtDNA-encoded subunits to 
form the holoenzyme. The nDNA-encoded 
subunits are necessary for the assembly/ 
stability of the holoenzyme (5), and to regulate 
the catalytic activity of complex IV (6,7).  
More than 20 assembly factors 
required for correct COX function have been 
described in yeast, albeit the specific function 
of many of these factors remains elusive 
(reviewed in 8). Assembly factors are proteins 
involved in the biogenesis of the complex, 
which are not present in the mature complex. 
They are involved in different biological 
processes, for example in the biogenesis and/ 
or insertion of prosthetic groups (9-12), 
regulation of mt-CO1 translation (13), and 
stabilization of the mt-CO1 and mt-CO3 
transcripts (14,15). 
 Transcription of genes in bacteria and 
Archaea occurs in polycistronic messenger 
RNA, whereas in Eukaryota the majority of 
genes are transcribed monocistronically (16). 
However, there are some exceptions in 
Eukaryota where genes are transcribed in 
polycistronic messages and in general, these 
polycistronic genes tend to be involved in the 
same biological process as occur in bacteria 
(17-20). 
Mitochondrial gene expression is 
regulated by several nuclear encoded proteins, 
including the mitochondrial transcription 
factor B1 (mtTFB1) (21). mtTFB1 is dual-
function protein that can activate mtDNA 
transcription in vitro (22) and act as rRNA 
methyltransferase in vivo (23,24). Previous 
work from our group in cultured Drosophila 
cells indicated a major role for mtTFB1 in 
mitochondrial translation (25). And more 
recently, Larsson and coworkers have 
corroborated this data in mammals, where they 
showed methylation of the 12S rRNA 
mediated by mtTFB1 is required for assembly 
of the mitochondrial ribosome, and therefore 
for mitochondrial translation (26). The 
mtTFB1 gene in Drosophila melanogaster was 
annotated as the protein coding gene number 
CG7319 in the fly genome database 
(http://flybase.org). More recently, the 
FlyBase Genome Annotators have published 
changes affecting the annotation of the 
mtTFB1 gene that indicates the existence of an 
upstream Open Reading Frame (uORF) in its 
5’-untranslated region. The putative protein 
coding gene is annotated as CG42630 in the 
flybase database (http://flybase.org). Here we 
show that CG42630 is transcribed in a 
bicistronic RNA messenger with the mtTFB1 
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gene and is expressed in flies. Blast of the 
novel uORF indicated 42% amino acid identity 
with the human annotated Coiled-Coil Domain 
Containing protein 56, (CCDC56; 
NP_001035521.1). Thus, we propose 
Drosophila CG42630 as the homologue of 
human CCDC56. Although the function of 
CCDC56 is unknown, it is highly conserved in 
higher eukaryotes. To study the function of the 
CCDC56 protein, we generated a Drosophila 
melanogaster knockout model by inducing 
genomic deletions by imprecise P-element 
excision. Our results indicate that the CCDC56 
homolog is a mitochondrial protein required 
for COX activity and assembly in Drosophila 
melanogaster, suggesting a role as a COX 
assembly factor. 
 
EXPERIMENTAL PROCEDURES  
 
Drosophila strains and genetics  
All fly crosses and stocks were grown at 25ºC 
on a standard Drosophila medium. ccdc56D6 
and ccdc56D11 mutants were generated by 
inducing the transposition of the SUPor-
P[kg07792] P element insertion using standard 
procedures (27). Deletion breakpoints of 
alleles were determined by PCR followed by 
sequencing using specific primers (Fig 3B-C). 
Sequences were assembled and analyzed using 
the Vector NTI software (Invitrogen). 
Transgenic lines for the pUASP-CCDC56, 
pUASP-mtTFB1 and pUASP-cDNAbi 
constructs were generated by the injection of 
Drosophila embryos (BestGene).  
 
Identification and sequence analysis of 
bicistronic ccdc56-mtTFB1 cDNA and 
CCDC56  
cDNAs from Drosophila control larvae (w1118 
and Oregon R-C) and Schneider cells were 
prepared using the First Choice RLM-RACE 
cDNA amplification kit (Ambion). 5’ RACE 
was performed using the following specific 
primers for Drosophila mtTFB1 cDNA 
(CG42631, formerly CG7319): R1, R2 and 
R3, depicted in Fig1A.. RACE products were 
cloned into the pCRII-TOPO vector 
(Invitrogen) and sequenced. Sequence analysis 
was performed using Vector NTI Advance 10 
(Invitrogene Software). Human CCDC56 
(NP_001035521.1) and CCDC56 homologues 
were identified by BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) using 
the deduced amino acid sequence of the D. 
melanogaster CG2630 coding gene (28). 
Multiple sequence alignments of the predicted 
CCDC56 polypeptides were performed using 
the ClustalW 2.0.12 algorithm (29). 
 
Northern blotting 
Five µg of total RNA from control flies were 
resolved on a 1.2% agarose gel and transferred 
to a ZETA-PROBE GT membrane (Bio-Rad) 
following standard procedures. Invitrogen's 
0.5–10 Kb RNA Ladder was used as a 
molecular size marker. A PCR fragment of 
280 bp containing the complete ccdc56 ORF 
(261 bp) was used as a ccdc56-specific probe. 
This probe was amplified by PCR from the 
pUASP-CCDC56 construct using primers 
9558F and 9559R (see below). The specific 
probe for the mtTFB1 coding sequence (322 
bp) was obtained by PCR amplification using 
the primers F9: 5’- 
AGCACATCCCGGACACCTCA-3’ and R4: 
5’-TTTAGGGGAATTAGCTTGACG-3’. 
Probes were radiolabeled with [P32]-dCTP 
using the Amersham Rediprime II Random 
Prime Labeling System (GE Healthcare) 
following the manufacturer’s instructions. 
 
Phenotyping analysis  
We carried out 2-hour egg lays from the 
control w1118 stock and the stable mutant 
stocks ccdc56D6/TM6b-Tb and 
ccdc56D11/TM6B-Tb. To determine if mutant 
larvae were developmentally arrested, 
developmentally delayed, or merely slow 
growing, their mouth hooks were examined 
daily under the microscope from the fifth day 
after egg laying (AEL). Fly vials were also 
photographed daily.  
 
Bacterial expression of d-CCDC56 and 
generation of anti d-CCDC56 antibody 
To express d-CCDC56 in Escherichia coli, a 
PCR fragment encoding the d-CCDC56 open 
reading frame was cloned into the pRSET-B 
vector (Invitrogen) cut with NcoI and HindIII. 
Primers used were: Fw: 5’-
TTCCATGGCGGCGTCGGAGCAGGGACC
-3’ and Rv: 5’-
AGAAGCTTCTAGGAAGACACCTTCTTG
GGCTC-3’. Polyclonal antibody was 
generated using standard procedures. 
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Constructs for the generation of transgenic 
flies  
The bicistronic ccdc56-mtTFB1 cDNA (1574 
bp) was obtained from the cDNA clone 
LD40326 (GenBank AY069635) and cloned 
into the BglII/XbaI restriction sites of the 
pUAST transformation vector to generate the 
pUAST-cDNA-bi construct. To generate the 
pUASP-ccdc56 vector for transformation, a 
fragment containing exclusively the complete 
ccdc56 ORF (261 bp), was amplified by PCR 
using the following primers: 9558F: 5’-
TTTAGCAGCGTTTATAATGTCG-3’ and 
9559R: 5’-
TAGGGATAACTAACGCGGACA-3’, 
subcloned into the pCAP vector (Roche) and 
cloned into the NotI/XbaI restriction sites in 
the pUASP vector. To generate the pUASP-
mtTFB1 construct, mtTFB1 ORF (990 bp) was 
obtained by digestion with KpnI/NotI of the 
pBluescript II KS+ vector (Stratagene) 
containing the mtTFB1 cDNA and cloned into 
the pUASP vector for transformation.  
 
Drosophila CCDC56-FLAG construct  
D. melanogaster CCDC56 ORF was amplified 
by PCR from the pUASP-ccdc56 construct 
indicated above, using the following primers: 
F 5’-
TTGGTACCATGTCGGCGTCGGAGCAGG
GACC-3’ and R 5’-
TTGCGGCCGCCTACTTGTCGTCATCGT
CTTTGTAGTCGGAAGACACCTTCTTGGG
CTCC-3’containing the FLAG epitope at the 
C-terminal and the KpnI/NotI sites needed for 
cloning into the mammalian expression vector 
pcDNA3 (Invitrogen). Fidelity of the clones 
was confirmed by sequencing. 
 
Transfection and generation of CCDC56-
FLAG overexpressing cell lines 
 Human HeLa cells were grown in DMEM 
(GIBCO-BRL) supplemented with 5% fetal 
bovine serum (GIBCO-BRL). 1.5 * 105 HeLa 
cells were plated on coverslips and transfected 
with 2 µg of the pcDNA3-d-ccdc56-FLAG 
construct. Lipofectamine (Invitrogen) was 
used as a transfection reagent, following the 
manufacturer’s instructions.  
 
Immunohistochemistry 
To label the mitochondrial compartment, cells 
were incubated for 30 min with 250 nM of the 
mitochondrial dye MitoTraker red (Invitrogen) 
24 h after transfection, washed, and fixed for 
15 min in 2% paraformaldehyde. Primary anti-
FLAG antibody (1:1000, Stratagene) and 
secondary Alexa Fluor 488 anti-mouse 
antibody (1:200, Molecular Probes) were used. 
Images were collected using a Confocal 
microscope (Leica). 
Imaginal discs from third instar larvae of each 
genotype were dissected in PBS and fixed with 
4% paraformaldehyde in PBS for 20 min at 
room temperature. They were blocked in PBS, 
1% bovine serum albumin, 0.3% Triton X-100 
for 1 h, incubated with the primary antibody 
overnight at 4°C (dilution 1:50), washed, and 
incubated with the appropriate secondary 
antibody for 2 h at room temperature in the 
dark (dilution 1:200). Finally, they were 
washed and mounted in Vectashield (Vector 
Laboratories). Primary antibodies used were 
rabbit anti-phosphohistone 3 (Sigma-Aldrich) 
and rabbit anti-caspase 3 (Cell Signaling 
Technology). Secondary antibodies were 
coupled to the fluorochromes Alexa Fluor 647 
or Alexa Fluor 555 (Invitrogen). Preparations 
were visualized under a Leica TCS SP2 laser-
scanning microscope.  
 
Mitochondrial enzyme assays and mtRNA 
and mtDNA quantification 
For enzymatic activity measurements, 
mitochondria-enriched homogenates were 
prepared from approximately 30 third instar 
larvae ground in SETH buffer (250 mM 
sucrose, 2 mM EDTA, 100 U/L heparin, 10 
mM Tris-HCl, pH 7.4), fractionated by 
differential centrifugation and sonicated (6s, 
15 microns at 4ºC). The activities of the 
respiratory chain complexes I, II, III and IV 
and the mitochondrial mass marker citrate 
synthase were measured by 
spectrophotometric methods as previously 
described (30) and expressed in nanomoles of 
substrate catalyzed per minute per milligram 
of protein. For mtRNA quantification, RNA 
was extracted using TRIzol reagent 
(Invitrogen) and 1 µg from each genotype was 
converted into cDNA and amplified in a 7900 
Fast Real Time PCR System (Applied 
Biosystems) using the Taqman probes. For 
relative quantification of mtDNA, genomic 
DNA was isolated from third instar larvae and 
quantified using standard methods. Ten ng of 
each DNA were used as template. Taqman 
probes for mt-ND5 and mt-CO1 were used.  
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Immunoblotting/ subcellular fractionation 
Thirty µ g of each mitochondrial protein 
extract, obtained by differential centrifugation, 
were separated on 10% or 15% SDS-PAGE 
gels and transferred to Immobilon P PVDF 
membranes (Millipore). Filters were pre-
incubated for 1 h in 5% skim milk in TBS-
0.1% Tween 20, followed by an overnight 
incubation with the corresponding primary 
antibody. Monoclonal antibody against Porin 
(1:2000, VDAC) was obtained from Molecular 
Probes, polyclonal antibody against d-
CCDC56 was generated as described above 
(1:50), and polyclonal antibody anti-mtTFB1 
was previously generated by Dr. L. S. Kaguni 
(1:1000, (25). For subcellular fractionation, 
Drosophila melanogaster embryos were 
homogenized in 250 mM sucrose, 10 mM TES 
and 1mM EDTA pH 7.4 with 5 strokes at 1000 
rpm using a motor-driven Teflon pestle. 
Homogenates were then centrifuged at 900g 
for 10 minutes at 4ºC and the supernatant was 
centrifuged again at 9000g for 10 minutes at 
4ºC to obtain the mitochondrial fraction 
(pellet) and post-mitochondrial supernatant. 
Fifty µg of each fraction were loaded onto 
12% SDS-PAGE gels, transferred to PVDF 
membranes and probed with anti- Porin 
(1:1000), anti-GAPDH (1:1000, Stressgene) 
and anti-d-CCDC56 (1:50) antibodies. 
 
Blue native gel analyses 
Mitochondrial pellets isolated from larvae 
were resuspended in 1.5 M aminocaproic acid, 
75 mM Bis-Tris (pH 7.0). Respiratory chain 
complexes were extracted with 2% 
laurylmaltoside for 20 min on ice, and then 
centrifuged for 30 min at 4ºC. Blue Native 
Polyacrilamide Gel Electrophoresis (BN-
PAGE) and 2D electrophoresis (2D SDS-
PAGE) were performed as described (31), 
loading 40 µg of mitochondrial protein per 
lane. A 4-18% native acrylamide gradient gel 
was used for the first dimension and 10% 
acrylamide gels were used for electrophoresis 
in the second dimension. Proteins were 
transferred overnight to a nitrocellulose 
membrane. Anti mt-CO3 (Invitrogen) was 
used at a 1:200 dilution; polyclonal antibody 
against β -ATPase, generated in our lab (32) 
was used at 1:1000, and secondary goat-anti 
mouse antibody IgG-HRP (provided by 
Zymed Laboratories) was used at 1:2000. 
 
Statistical analysis 
Statistical data analysis was performed with 
Prism 4.03 software (GraphPad Software). 
One-way ANOVA (plus Bonferroni post-test) 
and Student´s t-test were used to determine 
statistical significance of the results, which 
was assumed at p <0.05. 
 
RESULTS 
 
The D. melanogaster gene CG42630 is 
expressed in a bicistronic mRNA with 
mtTFB1 and encodes a novel conserved 
protein, CCDC56. 
A search in the Drosophila genome 
database (http://flybase.org) indicated the 
existence of an upstream Open Reading Frame 
(uORF) in the 5’-UTR of the mtTFB1 
transcript located in the first exon of the 
mRNA (Fig1A). This putative polypeptide is 
denoted as CG42630 in FlyBase, and the 
biological processes in which it is potentially 
involved are unknown. To confirm the 
existence of a bona fide bicistronic transcript 
of CG42630-mtTFB1, we isolated mRNA 
from Drosophila strains and from Drosophila 
SL2 Schneider cells, and carried out Rapid 
Amplification of cDNAs ends (RACE, Fig1B), 
using the strategy described in Materials and 
Methods. We sequenced the cDNA clones 
obtained by 5’-RACE from different 
Drosophila strains (w1118, n=8; Oregon R-C, 
n=6) and from cultured Schneider cells (n=6), 
and in all cases sequence analyses detected a 
single transcript with a heterogeneous 
transcription start point located upstream from 
the CG42630 uORF (Fig1B). We excluded the 
presence of transcripts coding only for 
CG42630 by 3’-RACE (data not shown). 
These results suggest strongly that d-mtTFB1 
and the putative gene, CG42630, are 
transcribed in the same mRNA, and therefore 
are encoded in a bicistron. We tested the 
existence of this CG42630-mtTFB1 bicistronic 
mRNA by Northern blot in total RNA 
extracted from D. melanogaster flies (Fig1C) 
using two different probes: a 280 nucleotide 
(nt) probe specific for the CG42630 coding 
sequence, and a 320 nt probe specific for the 
mtTFB1 coding sequence (see Materials and 
Methods). We detected with both probes a 
single signal of about the expected size of 
1574 bp (Fig1A), confirming the existence of 
the CG42630-mtTFB1 bicistronic structure in 
D. melanogaster. 
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The putative CG42630 gene encodes a 
predicted polypeptide of 87 amino acids 
(http://flybase.org). The deduced amino acid 
sequence from Drosophila CG42630 was used 
to perform a BLAST analysis of the human 
genome (28), and a single protein of unknown 
function was identified: the Coiled-Coil 
Domain Containing protein 56, CCDC56. We 
found a 42% amino acid identity between D. 
melanogaster and its human homolog. 
CCDC56 has two putative domains: a single-
pass transmembrane domain (aa58 to aa78 in 
humans and aa49 to aa69 in D. melanogaster) 
and a protein-protein interaction coiled-coil 
domain (from aa79 to aa104 in humans and 
from aa70 to aa 87 in D. melanogaster) 
(Fig1E). We refer to the Drosophila CG42631 
gene as ccdc56. 
In contrast to the bicistronic structure 
detected in flies, human CCDC56 is encoded 
in a single transcript and the gene is located on 
chromosome 17q.21.31 (Entrez gene ID 
28958). Human CCDC56 protein contains 106 
aa protein (Swiss Prot Q9Y2R0). Orthologous 
CCDC56 proteins are present in metazoans 
showing a high degree of conservation 
(Fig1D), but they are absent in yeast and 
plants. No mitochondrial signal peptide was 
detected in the amino acid sequences of the 
Drosophila and human CCDC56 proteins 
using the bioinformatic programs TargetP and 
iPSORT. 
 
CCDC56 is a mitochondrial protein. 
In prokaryotes, operons encode factors 
that are usually involved in the same metabolic 
pathway or biological process (33). Because 
mtTFB1 is an essential protein involved in 
mitochondrial translation, we first examined 
the possibility that CCDC56 is also located in 
mitochondria (25,26). We cloned the 
Drosophila CCDC56 ORF tagged with the 
Flag epitope (FLAG) at the carboxyterminal 
end (d-CCDC56-FLAG), and transiently-
transfected cultured HeLa cells (Fig2). Using 
anti-FLAG antibodies, we observed a clear 
colocalization with the mitochondrial-specific 
dye MitoTracker Red, indicating that the 
tagged CCDC56 version has a mitochondrial 
localization (Fig2C).  
In order to detect the endogenous 
protein in the fly, we generated a polyclonal 
antibody against the Drosophila CCDC56 
polypeptide. Immunoblot analysis of 
subcellular fractions of wild type embryos 
demonstrated that endogenous Drosophila 
CCDC56 (d-CCDC56) is expressed and 
localized to the mitochondrial fraction 
(Fig2D). The protein shows an electrophoretic 
mobility that corresponds to a molecular mass 
of approximately 10 KDa, in accordance with 
the predicted size of the Drosophila CCD56 
protein. Monoclonal anti-porin antibody was 
used as a mitochondrial marker.  
 
Generation of ccdc56 knockout alleles 
To study the in vivo function of 
CCDC56 we generated transgenic flies 
harbouring ccdc56 loss-of-function alleles. To 
generate deletions that affect specifically the 
ccdc56 gene, we mobilized the P{SUPor-
P}mtTFB1[KG07792] transposon located in the 
proximal 5’-region of the gene using standard 
procedures (27). From approximately 100 
independent lines in which the P element had 
been removed, two lines carrying deletions 
that map specifically in the ccdc56 coding 
sequence without affecting the mtTFB1 coding 
sequence, ccdc56D6 and ccdc56D11, were 
selected (Fig3A-C). A Drosophila line 
harbouring an allele in which the P element 
was excised precisely without removing 
additional DNA sequence was used as a 
control (designated Control 2, Fig3D-E). The 
control flies were obtained by the same 
process as those harboring the deletions. 
Homozygous ccdc56D6/D6 and ccdc56D11/D11 
flies are not viable and die in the third larval 
instar stage, suggesting that ccdc56 is essential 
for development. ccdc56D6/D11 trans-
heterozygotes showed the same lethal 
phenotype as homozygous ccdc56D6/D6 and 
ccdc56D11/D11 flies, indicating that these alleles 
did not complement each other, which is 
expected if the molecular lesion affects the 
same gene. To map precisely the deletion 
breakpoints, we PCR-amplified and sequenced 
the genomic region flanking the P element 
(Fig3A-C). The ccdc56D6 allele harbors a 570 
bp-long deletion that includes the ATG-
initiation codon and the first 23 nucleotides of 
the ORF of CCDC56 (Fig3B). The ccdc56D11 
allele shows a larger deletion of 1068 bp, 
comprising the complete ccdc56 coding 
sequence and the first 26 nucleotides of the 
intron in the ccdc56-mtTFB1 mRNA (Fig 3C).  
 
Phenotype of ccdc56D6/D6 and ccdc56D11/D11 
Drosophila fly lines 
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Heterozygous ccdc56D6/TM6B-Tb and 
ccdc56D11/TM6B-Tb flies are viable and 
fertile, and can be distinguished easily by the 
genetic marker Tubby (Tb, generating small 
pupa size) that allows classifying the progeny. 
When raised at 25ºC, heterozygous mutant 
larvae, like control larvae, reached the third 
larval stage at 4-5 days After Egg Laying 
(AEL). However ccdc56D6/D6 and ccdc56D11/D11 
homozygotes took between 10-12 days to 
reach the third larval stage, monitored by 
analyzing the mouth hook morphology 
(Fig4B), indicating a developmental delay. 
Homozygous ccdc56D6/D6 and ccdc56D11/D11 
third instar larvae were much smaller than 
controls, remained in this stage for over 20 
days and then died before pupariation (Fig4A). 
We used the ccdc56D11/D11 mutant to perform 
immunocytochemical analysis in wing 
imaginal discs, the proliferating larval 
epithelial cells that form the adult wings of the 
fly. Mutant imaginal discs were smaller than 
controls. Indeed, mutant wing discs showed a 
decreased number of mitotic cells, as seen by a 
reduction in the number of cells that express 
phosphorylated Histone 3, a mitotic cell 
marker (Fig4C). ccdc56D11/D11 mutants also 
showed increased levels of apoptosis in the 
wing discs as detected with an antibody that 
recognizes activated Caspase3, whereas cell 
death in control wing discs was minimal 
during most of the larval development 
(Fig4D). These results indicate that two of the 
processes that contribute to tissue growth, cell 
division and cell survival, are compromised in 
the ccdc56D11/D11 mutant.  
 
The phenotype of ccdc56D6/D6 and 
ccdc56D11/D11 Drosophila lines is produced by 
the absence of CCDC56. 
 Because both deletions remove a large 
5’-region upstream of the ccdc56/ mtTFB1 
genes that potentially contain critical promoter 
elements involved in regulating their 
transcription, we used RT-PCR to identify 
truncated transcripts encoding the mtTFB1 
gene in the mutant lines. Interestingly, in both 
the homozygous D6 and D11 lines the levels 
of truncated ccdc56/ mtTFB1 transcript ranged 
between 20-30% as compared to the wild type 
controls (Fig3E). Detailed analysis using 5’-
RACE revealed the presence of a family of 
transcripts originating from the 5’-upstream 
region close to the breakpoints (Fig3B-C), 
indicating clearly that these regions still 
contain promoter activity. All the detected 
transcripts expressed in the mutant lines 
contained the complete d-mtTFB1 coding 
sequence (Fig3B-C) but as expected, they 
lacked the complete ccdc56 coding sequence. 
Accordingly, no CCDC56 was detected by 
immunoblot analysis of mitochondrial extracts 
from ccdc56D6/ D6 and ccdc56D11/D11 larvae, 
indicating that both are ccdc56 null alleles 
(Fig3F); in contrast, mtTFB1 is present in 
mitochondrial extracts prepared from the 
mutant larvae (Fig3F). 
To demonstrate further that the lethal 
phenotype observed in the mutants isolated in 
our screen was due exclusively to the loss of 
CCDC56 function, we overexpressed 
independently ccdc56 or mtTFB1 in both D6 
and D11 homozygous genetic backgrounds. 
We cloned the ccdc56 and mtTFB1 coding 
sequences in the pUASP vector and generated 
several UAS-CCDC56 and UAS-mtTFB1 
transgenic lines (See Materials and Methods). 
We selected two independent lines for each 
transgene that were viable upon homozygosis, 
and we generated stable stocks carrying these 
UAS constructs in homozygosis on 
chromosome II, and the ccdc56D6 or ccdc56D11 
alleles balanced over the TM6B-Tb 
chromosome on chromosome III. To direct the 
expression of the transgenic UAS constructs 
we used the ubiquitous arm-GAL4 driver, in 
which expression of the transcription activator 
factor GAL4 is driven by the armadillo 
promoter (ß-catenin homolog in mammals). 
We found that homozygous mutant larvae 
carrying one copy each of the UAS-CCDC56 
and the arm-GAL4 transgenes developed 
beyond the third larval stage, reaching the 
pupal stage (Fig5A). Two independent 
transgenic lines expressing CCDC56 produced 
62.8 ± 1.8 % and 55.9 ± 4.8% of the 
homozygous mutant pupae progeny expected 
for a neutral allele (Table 1). However, the 
UAS-mtTFB1 construct directed by the same 
driver was not able to rescue lethality at the 
third larval stage for mutants carrying the D6 
or D11 deletion allele (to simplify, only data 
are shown regarding the ccdc56D11 allele, 
Table 1 and Fig5A). The presence in a mutant 
background of a copy only of the arm-GAL4 
driver or a copy only of the UAS-CCDC56 
construct did not rescue mutant lethality. 
Accordingly, all pupae scored in the vials were 
heterozygous for the mutant allele (Table 1 
and Fig5A). 
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 Quantification of transcript levels by 
qRT-PCR in homozygous third instar larvae of 
the different genotypes showed that the arm-
GAL4 driver restores ccdc56 mRNA levels to 
73.9% ± 0.1 of controls in a D11 mutant 
background (Fig5B, white bar). Despite this 
increase in mRNA levels, CCDC56 protein 
measured by immunoblot analysis was 
increased only to 15% of control levels 
(Fig5C). This result indicates that the 
induction of low levels of CCDC56 is 
sufficient to rescue the developmental arrest of 
the ccdc56D11/D11 mutant, permitting pupation 
of the larvae and most of the metamorphosis 
program of the flies (Fig5A). The fact that the 
rescue of lethality was not complete may be 
explained by the slight increase of the 
CCDC56 protein obtained under these 
conditions. Accordingly, by restoring 
CCDC56 to control levels (by inducing the 
expression of the bicistron), we obtained a 
stronger rescue of lethality: 96.77% ± 1.6 of 
the ccdc56D11/D11 mutant progeny reached the 
pupal stage and 34.5% ± 4.5 reached the adult 
stage. As expected, the transcript levels 
assessed with the probe that recognizes the 
bicistronic mRNA were nearly absent in the 
D11 homozygous larvae for all transgene 
combinations, as the D11 deletion (shown in 
Fig3C) includes part of the recognition 
sequence for this probe (Fig5B, grey bars; 
Fig3E probe1). 
 
ccdc56 knockout flies show a severe isolated 
cytochrome c oxidase deficiency. 
To study the effect of the absence of 
CCDC56 on mitochondrial function we 
measured the OXPHOS enzyme activities in 
control and homozygous mutant third instar 
larvae. Both ccdc56D11/D11 and ccdc56D6/D6 
mutant larvae showed a dramatic reduction in 
cytochrome c oxidase (COX, complex IV, 
CIV) activity (Fig6A). The decrease in COX 
activity was almost complete when activities 
were normalized with respect to citrate 
synthase activity, an indicator of total 
mitochondrial mass (data not shown). This 
decrease in COX activity in ccdc56D11/D11 
mutant larvae was confirmed by Blue Native 
PAGE (Fig7A). Interestingly, the enzyme 
activities of the remaining OXPHOS 
complexes were either unaffected or increased 
significantly (complexes I and II in 
ccdc56D11/D11 mutants, Fig6A), a result that 
may reflect a compensatory response to the 
dramatic reduction of COX activity in the 
mutants. Most interestingly, a huge increase 
(4-5 fold) in mtDNA levels was also observed 
in mutant mitochondria as compared to 
controls (Fig6B). In addition, a moderate 
increase was observed in the steady-state 
levels of mitochondrial RNA (mtRNA) 
transcripts (Fig6C), including the small 
ribosomal RNA (rRNA-12S) and the 
cytochrome c oxidase transcripts mt-CO1, mt-
CO2 and mt-CO3 that are increased 2-to-2.5-
fold (Fig6C). The increased mtRNA transcript 
levels in both mutants were confirmed by 
Northern-blot analyses (data not shown). 
The ubiquitous expression of the UAS-
CCDC56 construct in a ccdc56D11/D11 genetic 
background induced a significant increase in 
COX enzyme activity (37.4% ± 0.043 vs 
19.5% ± 0.040; Fig7C). As expected, 
expression of the UAS-mtTFB1 construct 
under the same conditions had no effect, 
showing similar levels of COX activity as the 
mutants (14.3% ± 0.043 Fig7C). These results 
suggest strongly that CCDC56 is required for 
cytochrome c oxidase function in Drosophila 
melanogaster. 
 
ccdc56 knockout flies show a severe 
reduction of fully-assembled complex IV  
Because the only OXPHOS complex 
affected in ccdc56 knockout flies is complex 
IV, we next explored by Blue Native-PAGE 
analysis if the assembly of this complex was 
affected in the mutants. Several antibodies 
against mammalian mitochondrial and nuclear-
encoded COX subunits were tested against 
Drosophila protein extracts, but unfortunately 
most showed little or no cross reactivity (data 
not shown). To determine the levels of fully-
assembled complex IV in our mutant flies we 
performed 2D Blue Native PAGE followed by 
immunoblot analysis with an anti-mt-CO3 
antibody that was able to recognize 
Drosophila mt-CO3. In ccdc56D11/D11 and 
ccdc56D6/D6 mitochondria, we observed a 
dramatic decrease in the levels of fully- 
assembled holo-COX (indicated by complex 
S4, Fig7A). However, we did not detect the 
accumulation of any subcomplex or putative 
assembly intermediate in our mutants, at least 
under the conditions tested (Fig7A). To 
demonstrate that the absence of CCDC56 
function was responsible for the mutant CIV 
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assembly defect, we attempted to rescue this 
phenotype by inducing the ubiquitous 
expression of a UAS-CCDC56 transgene in a 
mutant background. Consistent with our 
hypothesis, we observed a recovery of fully- 
assembled complex IV levels in mutants 
expressing UAS-CCDC56 (Fig7A, third 
panel), but not when we overexpressed 
mitochondrial translation factor B1 (Fig7A, 
fourth panel). This result indicates that 
CCDC56 is required for the proper assembly 
and/ or stability of mitochondrial complex IV 
in Drosophila melanogaster. 
 
DISCUSSION 
 
We have identified in D. melanogaster 
a novel mitochondrial protein, CCDC56, 
which is evolutionarily well conserved in 
metazoans. CCDC56 belongs to the Coiled-
Coil Domain Containing family of proteins 
and although its function is unknown, we 
found that loss of CCDC56 results in a severe 
isolated enzyme deficiency and assembly 
defect of mitochondrial cytochrome c oxidase. 
This indicates that CCDC56 plays a critical 
role in the biogenesis and activity of complex 
IV, and is therefore essential for the function 
of the OXPHOS system.  
In D. melanogaster, CCDC56 is 
annotated in a single transcription unit together 
with mitochondrial transcription factor B1 
(Flybase, http://www.flybase.org). Blast 
analyses showed that this organization is also 
present in the other 11 Drosophila species for 
which sequence data is available (data not 
shown). Northern blot and RACE experiments 
demonstrate that ccdc56 and mtTFB1 are 
encoded on the same functional bicistronic 
transcript in D. melanogaster. Although the 
presence of operon-like structures is not 
frequent in eukaryotes, a comparative 
evolutionary study of 12 Drosophila genomes 
predicted the presence of 123 novel 
polycistronic transcripts (34). More recently, 
another comparative genomic approach using 
D. melanogaster and Anopheles gambiae 
transcript annotations and dipteran expressed 
sequence tags was performed in order to 
identify transcripts with upstream Open 
Reading Frames (uORFs). Interestingly, in 
dipterans conserved uORFs occur 
preferentially in transcripts encoding 
mitochondrial proteins and methyltransferases 
(35). The uORF usually encodes smaller 
proteins than those encoded in the main ORF 
(mORF). Some examples in Drosophila are 
the translocase of the inner membrane 10, Tim 
10 (Flybase annotation: CG9878), and the 
translocase of the inner membrane 9b, Tim 9b 
(CG17767). It is possible that at least some of 
these uORFs are vestiges of ancient 
prokaryotic operons that originated in the 
mitochondrion and were transferred to the 
nuclear genome over time. Another possible 
explanation would be that these structural 
organizations favor a coordinated regulation of 
genes involved in similar biochemical 
pathways (16).  
We further investigated if this novel 
peptide is targeted to the mitochondrial 
compartment, like mtTFB1, by transfecting 
HeLa cells with a recombinant d-
CCDC56FLAG-tagged protein. We observed a 
clear mitochondrial localization of CCDC56, 
and in addition we detected by 
immunoblotting the endogenous CCDC56 
only in the mitochondrial fraction. Therefore, 
and in agreement with the results obtained in 
the comparative genomic study, we describe 
here a new case of a bicistronic transcript in 
which both proteins have a mitochondrial 
function. To our knowledge, this is the first 
demonstration of a eukaryotic bicistron in 
which both proteins have a mitochondrial 
function that is demonstrated to be functional 
in vivo.  
We explored the consequences of the 
lack of function of mitochondrial protein 
CCDC56 by generating two independent 
Drosophila knockout lines via inducing the 
excision of a P element located in the promoter 
region of the ccdc56-mtTFB1 genes. Its 
imprecise excision removed part of the 
flanking DNA and therefore generated specific 
deletions. Transcripts detected by RACE in the 
ccdc56D6 knockout line lack the first 23 
nucleotides and therefore the translation start 
codon of ccdc56, while no ccdc56 containing 
transcripts were detected in the ccdc56D11 
knockout line. As expected, CCDC56 was not 
detected in mitochondrial extracts from any of 
the mutant lines, indicating a total absence of 
CCDC56 protein in homozygous ccdc56D6 and 
ccdc56D11 animals. Furthermore, we have 
demonstrated that both mutant lines retained 
mtTFB1-encoding transcripts and mtTFB1 
protein, although in lower levels as compared 
to controls. Finally, we used the UAS-GAL4 
system (36) to promote independent 
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expression of CCDC56 or mtTFB1 in a mutant 
background. Overexpression of CCDC56 but 
not mtTFB1 rescued all mutant phenotypes: 
developmental delay, larval lethality, 
decreased complex IV enzyme activity and 
reduction in the levels of fully-assembled 
complex IV. Previous results have shown that 
mtTFB1 is essential for mitochondrial 
translation and more specifically for the 
stability of the small subunit of the 
mitochondrial ribosomes (12S rRNA) (25,26). 
Thus, if the functionality of mtTFB1 were 
affected in these alleles, we would expect a 
broader mitochondrial phenotype, not simply 
an isolated complex IV deficiency. 
Biochemical measurements and in-gel activity 
assays showed no decrease in the other 
respiratory chain complex activities in mutant 
animals, nor in complex V levels detected by 
Blue Native PAGE, which were even higher in 
the mutants. Taken together, our results 
indicate clearly that the phenotypes exhibited 
by the mutants were due exclusively to loss of 
CCDC56 function.  
The main biochemical phenotype of 
the lack of CCDC56 is a severe isolated 
complex IV deficiency, suggesting a role for 
CCDC56 in complex IV activity and 
consequently in the proper function of the 
OXPHOS system. Interestingly, in ccdc56 
knockout animals the OXPHOS defect elicits a 
compensatory response that causes a 
significant increase in mtDNA, in 
mitochondrial transcript levels, in OXPHOS 
activities in complexes I and II, and in levels 
of fully-assembled complex V. The molecular 
nature of this retrograde signaling is presently 
unknown. 
The OXPHOS defect caused by the 
CIV deficiency may be responsible for the 
developmental delay and 100% lethality in the 
third larval instar observed in ccdc56 knockout 
individuals. Mutant wing discs showed a 
reduced size, a decrease in cell proliferation 
and an increase in apoptosis levels as 
compared to controls. Larval to adult 
metamorphosis, which occurs during the pupal 
phase, is a high-energy requiring process. 
Thus, defects in the OXPHOS system, and 
consequently defects in ATP production, may 
be critical for successful completion of this 
developmental phase. This is supported by the 
phenotype observed in several other 
Drosophila mitochondrial gene mutants. For 
example, knockdown of mtTFB2, which 
encodes the mitochondrial transcription factor 
B2, or mutations in mitochondrial single-
stranded DNA-binding protein, both involved 
in mtDNA replication, also cause a 
developmental delay and a developmental 
arrest in the third larval instar (37,38). 
Complex IV assembly was studied 
initially by Nijtmans and colleagues (39), and 
subsequently by others (40) using Blue Native 
gel electrophoresis in human cell lines or 
tissues from patients with genetic defects in 
assembly factors (reviewed in 41,42). These 
studies describe complex IV biogenesis as a 
sequential process involving four 
intermediates, S1 to S4. The process starts 
with the incorporation of the prosthetic groups 
into mt-CO1 to form the subassembly 
intermediate S1. The last intermediate, S4 or 
holo-COX, constitutes the monomeric form of 
COX that subsequently dimerizes to form the 
active complex (39). Fully-assembled holo-
COX levels were decreased greatly in 
homozygous ccdc56D11 knockout larvae, as 
assessed by 2D Blue Native electrophoresis 
using an anti-mt-CO3 antibody. As expected, 
fully-assembled complex IV levels were 
restored partially by the ubiquitous expression 
of a UAS-ccdc56 transgene in the mutant 
background. These results indicate that 
CCDC56 is essential for the formation or 
stabilization of complex IV. No subassembly 
intermediates were detected under these 
conditions. mt-CO3 is incorporated into the S3 
intermediate, as indicated by the absence of 
fully-assembled holo-COX and the 
accumulation of S1 and S2 in cultured 
fibroblasts from patients lacking mt-CO3 (43), 
and reviewed in (44 and 42). Unfortunately, 
we tried several antibodies against other 
complex IV subunits with no success, so we 
cannot rule out the possible accumulation of 
other subassembly intermediates not 
containing mt-CO3 and thus, a role for 
CCDC56 in the early steps of complex IV 
biogenesis.  
Although the function of CCDC56 in 
flies remains unknown, because ccdc56 
knockout strains have extremely low levels of 
fully assembled complex IV it is tempting to 
suggest that CCDC56 constitutes a new 
complex IV assembly factor. In this regard, 
CCDC56 might participate in various steps of 
complex IV biogenesis: synthesis of 
mitochondrial COX subunits, synthesis of 
COX cofactors, the stability of different COX 
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subunits or their assembly into a functional 
holoenzyme. We suggest that it may function 
as a translational activator similar to TACO1 
(13), or as a  membrane insertion factor like 
OXA1 (45). Future experiments are warranted 
to explore these possibilities. Notably, 
increasing number of essential assembly 
factors for the biogenesis of a functional 
cytochrome c oxidase have been identified in 
S. cerevisiae (4). We found by Blast analysis 
that CCDC56 homologues are present in 
metazoans that show high conservation levels. 
However, no CCDC56 homologue was 
detected in yeast. The absence of a CCDC56 
homologue in yeast might be due to a low 
evolutionary conservation or could suggest the 
presence of novel levels of regulation of the 
complex IV assembly process in metazoans, 
thus highlighting the importance of using 
different model systems for the identification 
of the complete mitochondrial proteome.  
In conclusion, we have identified 
CCDC56 as a novel mitochondrial protein 
essential for cytochrome c oxidase activity in 
D. melanogaster and hence OXPHOS 
function. The high degree of conservation 
between the human and Drosophila proteins 
suggests strongly that the biological function 
of CCDC56 has been preserved in metazoans, 
making CCDC56 a new candidate gene to 
study in human mitochondrial diseases 
involving isolated cytochrome c oxidase 
deficiency. 
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FIGURE LEGENDS 
 
Fig1. The protein CCDC56, encoded in a bicistronic transcript together with mt-TFB1 in D. 
melanogaster, is conserved in metazoans. 
A) Genomic map of CG42630/ccdc56 and mtTFB1. Exons are indicated by boxes, coding regions are 
colored black for the CCDC56 and mtTFB1 proteins, and untranslated regions are represented in white. 
B) Bicistronic transcript determined by 5´-RACE from control flies (w1118 and OregonR-C) and cultured 
Schneider cell cDNAs. The transcription start points identified are depicted as (+1). The primers R1, R2 
and R3 used are represented in A. C) Bicistronic ccdc56-mtTFB1 mRNA detected by Northern blot using 
5 mg of RNA from w1118 (C1) and OregonR-C (C2) control larvae. The signal detected using a specific 
ccdc56 probe has the same migration as the signal detected when using a probe specific for mtTFB1. D) 
ClustalW alignment of Drosophila CCDC56 protein with CCDC56 sequences from other metazoan 
species. Accession numbers are as follows: fly (D. melanogaster)-CG42630-PA; zebrafish (Danio rerio)-
A8kB87; western clawed frog (Xenopus tropicalis)-A9UMl0-1; mouse (Mus musculus)-NP_080894.1; 
cow (Bos taurus)-Q3T0E3; human (Homo sapiens)-NP_001035521.1. Identical residues in all sequences 
(*), conserved substitutions (:) and semi-conserved substitutions (.) are noted in the alignment. E) 
Schematic diagram of the sequences of the human and Drosophila melanogaster CCDC56 proteins, 
showing the putative transmembrane and protein-protein interaction coiled-coil domains. 
 
Fig2. CCDC56 protein localizes to mitochondria. 
Immunocytochemistry of HeLa cells transfected with recombinant d-CCDC56-FLAG. A) MitoTracker 
staining is shown in red. B) The same cells immunostained for the FLAG epitope (green). The 
recombinant Drosophila protein colocalizes with the MitoTraker dye in the mitochondrial compartment 
(C). D) Immunoblots of protein extracts (50 µg) from subcellular fractions of control embryos, probed 
with anti-Drosophila-CCDC56 (d-CCDC56), anti-porin and anti-GAPDH antibodies. Total extracts, 
mitochondrial fraction (Mit) and post-mitochondrial supernatant (PMS) are shown.  
 
Fig3. Molecular characterization of the ccdc56D6 and ccdc56D11 alleles. 
A) Genomic map of the ccdc56 and mtTFB1 genes showing the P element insertion (SUPor-P[kg07792]; 
triangle). Exons are indicated by boxes, coding regions are colored black for the CCDC56 and mtTFB1 
proteins, and untranslated regions are represented in white. 5´-RACE from control (w1118) and mutant 
(ccdc56D6 and ccdc56D11) homozygous third instar larvae cDNAs identified the transcription start points 
depicted as (+1). The break points of the deletions generated in this work for the alleles ccdc56D6 and 
ccdc56D11 are shown in B) and C), respectively. The ratios of the mRNA as determined by 5´-RACE in 
the clones analyzed are represented (ccdc56D6/D6, n=8; ccdc56D11/D11, n=10). PCR products amplified with 
F5 and R4 primers (shown in A) from genomic DNA of third instar larvae are shown in D. Lane 1: DNA 
from the stock containing the P-element SUPor-P [kg07792], as a negative control. Lane 2: DNA from w1118 
control flies. Lane 3: DNA from excised flies without any deletion, used as an additional control. Lane 4: 
DNA from excised flies of the ccdc56D6/D6 strain, showing a 570 bp deletion. Lane 5: DNA from excised 
flies of the ccdc56D11/D11 strain, showing a 1168 bp deletion. E) Transcript levels determined by qRT-PCR 
in third instar larvae of control and deleted homozygous lines after normalizing to w1118 flies using 18S 
rRNA as an internal control. The two different Taqman probes used are depicted in B. Control 1: w1118 
flies. Control 2: excised flies without any deletion. F) CCDC56 and mtTFB1 protein levels determined by 
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immunoblotting of mitochondrial extracts (30 µg) of control and deleted homozygous larvae. Anti 
VDAC-porin antibody was used as a loading control. 
 
Fig4. Lack of CCDC56 causes arrest at the third larval stage.  
A) Size comparison of control (w1118) and homozygous mutant third instar larvae. Homozygous larvae for 
both alleles were smaller than control larvae in all cases tested. B) Mouth-hook morphology of control 
third instar larvae and mutant 15 days AEL larvae, indicating third instar. C) Wing imaginal discs from 
control (w1118) and homozygous ccdc56D11 third instar larvae were dissected and immunostained with 
anti-phosphohistone-3 (PH-3) antibody. Mutant wing discs showed lower cell proliferation levels as 
compared to controls. D) Anti-caspase-3 activated antibody was used to detect apoptotic signals in wing 
imaginal discs. Increased apoptotic levels were observed in homozygous ccdc56D11 flies as compared to 
control flies. Bar size is 50 µm. 
 
Table 1. Rescue analysis of ccdc56D11/ccdc56D11 flies. 
 a Homozygous ccdc56D11/ccdc56D11 pupae scored/ expected *100 of at least three replicate experiments. 
Homozygous ccdc56D11/ccdc56D11 pupae expected are 1/3 of the total progeny of the cross. The Tb 
marker enables the progeny classes to be distinguished. 
 
Fig5. CCDC56 expression rescues partially the mutant lethality phenotype.  
A) Flies homozygous for the ccdc56D11 allele reach only the pupal stage when they carry on chromosome 
II the UAS-CCDC56 and the arm-GAL4 transgenes. Larvae and pupae homozygous for the allele 
ccdc56D11 are of normal size. Larvae and pupae heterozygous for the deletion (genotype ccdc56D11 
/TM6B-Tb) carrying one copy of the Tb marker are smaller. B) qRT-PCR of CCDC56, bicistron and 
mtTFB1 mRNA relative to 18S rRNA, from homozygous ccdc56D11 third instar larvae combined with the 
different UAS-transgenes, and with or without the ubiquitous arm-GAL4 driver. The three Taqman 
probes used are depicted in the scheme. Data represent the mean ± SEM of at least three independent 
determinations; *p<0.05; **p<0.01; Student's t-test.  
C) Immunoblot of mitochondrial extracts (30 µg) from homozygous ccdc56D11 third instar larvae of the 
genotypes indicated, incubated with polyclonal anti-mtTFB1 and anti-CCDC56 antibodies, and with 
monoclonal anti VDAC-porin antibody.  
 
Fig6. ccd56 knockout flies exhibit an isolated complex IV enzyme deficiency.  
A) Respiratory chain enzyme activities (complexes I, II, III and IV) and citrate synthase activity were 
measured in mitochondrial extracts obtained from control and ccdc56 knockout  third instar larvae of 15 
days AEL. Both mutant alleles showed a severe decrease in complex IV enzyme activity. B) 
Quantification of relative mtDNA levels by qRT-PCR using ND5 and COXI as mitochondrial gene 
probes and 18S rRNA as a nuclear gene probe from control, ccdc56D6/D6 and ccdc56D11/D11 third instar 
larvae of 15 days AEL. C) Steady-state expression levels of representative genes from polycistronic 
transcripts from mitochondrial RNA were measured by qRT-PCR from ccdc56D6/D6 and ccdc56D11/D11 third 
instar larvae of 15 days AEL, and are shown relative to the levels found in control larvae, after 
normalization to 18S rRNA levels. Control larvae: genotype w1118; D6/D6: ccdc56D6/D6 and D11/D11: 
ccdc56D11/D11. Data shown in A, B and C represent the mean ± SEM of at least three independent 
determinations; *p<0.05; **p<0.01; ***p<0.001; ANOVA. 
 
Fig7. Loss of ccdc56 induces a complex IV assembly defect. 
A) 2D-BN/ SDS-PAGE analysis of mitochondrial extracts immunoblotted with an antibody against the 
mitochondrial-encoded subunit mt-CO3 of the cytochrome c oxidase complex. Mitochondria-enriched 
extracts were prepared from third instar larvae of the following genotypes: 1-control w1118; 2-mutant 
ccdc56D11/D11; 3-mutant ubiquitously expressing the UAS-CCDC56 transgene arm-GAL4/UAS-CCDC56; 
ccdc56D11/D11; and 4-mutant larvae expressing the UAS-mtTFB1 transgene under the same condition (arm-
	   16	  
GAL4/UAS-mtTFB1;ccdc56D11/D11). The lack of fully-assembled holo-COX exhibited by the ccdc56D11/D11 
mutant is rescued partially by overexpression of the UAS-CCDC56 transgene. S4, fully assembled 
complex IV. The previously identified mt-CO3-containing COX subcomplex S3 is indicated. B) First 
dimension of a duplicate BN-PAGE of mitochondrial extracts incubated with a polyclonal antibody 
against complex V as a loading control for the 2D- BN/ SDS-PAGE shown in A. C) Complex IV enzyme 
activity measured in mitochondrial extracts from homozygous ccdc56D11/D11 third instar larvae carrying 
the indicated constructs on chromosome II. Data were normalized to control larvae (w1118) and represent 
the mean SEM, n=3; *p<0.05; Student's t-test. 
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Table 1 
TABLE 1 
Rescue analysis of ccdc56D11/ccdc56D11 flies 
 
 
Genotype Chr II 
Nº of  
ccdc56D11/TM6B-Tb 
pupae scored 
Nº of 
ccdc56D11/ccdc56D11 
pupae scored 
Nº of 
Total pupae 
scored 
Mean (%) 
ccdc56D11/ccdc56D11 
pupae scored/expecteda ±SEM 
+/ + 1306 0 1306 0 
+/ arm-GAL4 1527 0 1527 0 
UAS-CCDC56-1/ + 1622 0 1622 0 
UAS-CCDC56-1/ arm-GAL4 1823 487 2310 62.8 ± 1.8 
UAS-CCDC56-2/ + 1786 0 1786 0 
UAS-CCDC56-2/ arm-GAL4 1502 356 1858 55.9 ± 4.8 
UAS-mtTFB1-1/ + 2039 0 2039 0 
UAS-mtTFB1-1/ arm-GAL4 1984 0 1984 0 
UAS-mtTFB1-2/ + 1629 0 1629 0 
UAS-mtTFB1-2/ arm-GAL4 1626 0 1626 0 
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Figure 5 
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Figure 6 
 
 
 
	   24	  
 
Figure 7 
 
 
